Hyderabad Pharma Infrastructure And Technologies - Company Profile

It is a financial services public not for profit company based in Hyderabad, Telangana, India, established in 2005.
2005 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Hyderabad Pharma Infrastructure And Technologies

Hyderabad Pharma Infrastructure And Technologies, a active public not for profit company, was established on 04 April 2005 in Hyderabad, Telangana, India. Engaging in equipment leasing & financing within the support service to organizations sector, it holds CIN: U45200TG2005NPL045814. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Policepatil Bakkareddy (Nominee Director), Kappuram Sunder Shyam (Nominee Director), Anandakumar Reddy Attivarapu (Nominee Director). Past directors included Rajat Kumar, Narayana Reddy Mundla, Sreedhar Cherukuri. Its latest AGM occurred on 23 December 2024, with the balance sheet filed on 31 March 2024. It is based at 6Th Floor, Parishrama Bhavanam Fatehmaidan Road, Hyderabad, Telangana, 500004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U45200TG2005NPL045814

  • Registration Number

    045814

  • Incorporation Date

    04 April 2005

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 20 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 25.55%
  • Profit Growth **** 79.91%
  • Ebitda **** 272.15%
  • Net Worth -0.94%
  • Total Assets -0.72%
Company report

Hyderabad Pharma Infrastructure And Technologies

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hyderabad Pharma Infrastructure And Technologies — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hyderabad Pharma Infrastructure And Technologies?
Current Directors
Name Designation Appointment Date Status
Policepatil Bakkareddy Nominee Director 10 Apr 2019 Current
Kappuram Sunder Shyam Nominee Director 10 Apr 2019 Current
Anandakumar Reddy Attivarapu Nominee Director 10 Apr 2019 Current
Shakthi Meyyappan Nagappan Managing Director 10 Apr 2019 Current
Sreenivasu Garikapati Nominee Director 04 Mar 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 26 Jun 2012 Past
Pramod Abcsdd Director 17 Jan 2011 Past
Pramod Abcsdd Nominee Director 27 Jun 2013 Past
Pramod Abcsdd Director 10 Jun 2013 Past
Pramod Abcsdd Director 12 Feb 2019 Past
Pramod Abcsdd Managing Director 01 Jul 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hyderabad Pharma Infrastructure And Technologies.

Hyderabad Pharma Infrastructure And Technologies, for the financial year ended 2022, experienced significant growth in revenue, with a 25.55% increase. The company also saw a substantial improvement in profitability, with a 79.91% increase in profit. The company's net worth dipped by a decrease of 0.94%.

Hyderabad Pharma Infrastructure And Technologies revenue growth over time
Hyderabad Pharma Infrastructure And Technologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 25.55%
*******
*******
*******
*******
Revenue from Operations
*******
 72.06%
*******
*******
*******
*******
Total Assets
*******
 -0.72%
*******
*******
*******
*******
Profit or Loss
*******
 79.91%
*******
*******
*******
*******
Net Worth
*******
 -0.94%
*******
*******
*******
*******
EBITDA
*******
 272.15%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hyderabad Pharma Infrastructure And Technologies?

In 2017, Hyderabad Pharma Infrastructure And Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hyderabad Pharma Infrastructure And Technologies?

Unlock and access historical data on people associated with Hyderabad Pharma Infrastructure And Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hyderabad Pharma Infrastructure And Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyderabad Pharma Infrastructure And Technologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hyderabad Pharma Infrastructure And Technologies
Recent Activity within the Organization
  • Annual General Meeting

    The activity Hyderabad Pharma Infrastructure And Technologies last Annual general meeting of members was held on 23 Dec 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Hyderabad Pharma Infrastructure And Technologies has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    The activity Sreenivasu Garikapati was appointed as a Nominee Director was appointed as a Nominee Director on 04 Mar 2022 & has been associated with this company since 4 years 1 day . was completed.

  • Director Appointment

    Progress on Policepatil Bakkareddy was appointed as a Nominee Director was appointed as a Nominee Director on 10 Apr 2019 & has been associated with this company since 6 years 10 months . was documented.

  • Director Appointment

    Progress on Kappuram Sunder Shyam was appointed as a Nominee Director was appointed as a Nominee Director on 10 Apr 2019 & has been associated with this company since 6 years 10 months . was documented.

  • Director Appointment

    Progress on Anandakumar Reddy Attivarapu was appointed as a Nominee Director was appointed as a Nominee Director on 10 Apr 2019 & has been associated with this company since 6 years 10 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hyderabad Pharma Infrastructure And Technologies?

The CIN of Hyderabad Pharma Infrastructure And Technologies is U45200TG2005NPL045814.

Where is Hyderabad Pharma Infrastructure And Technologies headquartered?

Hyderabad Pharma Infrastructure And Technologies is headquartered at 6Th Floor, Parishrama Bhavanam Fatehmaidan Road, Hyderabad, Telangana, 500004.

When was Hyderabad Pharma Infrastructure And Technologies incorporated?

Hyderabad Pharma Infrastructure And Technologies was incorporated on 04 April 2005.

Who are the current directors of Hyderabad Pharma Infrastructure And Technologies?

The current directors of Hyderabad Pharma Infrastructure And Technologies are

What is the primary industry of Hyderabad Pharma Infrastructure And Technologies?

The primary industry of Hyderabad Pharma Infrastructure And Technologies is Support Service To Organizations.

Is Hyderabad Pharma Infrastructure And Technologies a listed company?

Hyderabad Pharma Infrastructure And Technologies is unlisted.

What is the capital structure of Hyderabad Pharma Infrastructure And Technologies?

The authorized capital of Hyderabad Pharma Infrastructure And Technologies is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Hyderabad Pharma Infrastructure And Technologies?

The compliance status of Hyderabad Pharma Infrastructure And Technologies is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available